MM
About
Prior to joining CMEA, he co-founded Cell Signaling Technology, a spinout of New England Biolabs that develops drugs and tools to fight cancer. At Cell Signaling, Mike was responsible for sales, marketing and business development, during which time the company grew to 200 people and $50 million in annual sales. Mike has left an indelible mark during his brief tenure at CMEA. He helped manage the deal with Draths Corporation, a pioneer in producing chemicals from renewable feedstocks.
Investment Focus
- Location
- San Diego, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Michael
Search Investors